ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

USPH US Physical Therapy Inc

94.48
0.00 (0.00%)
Pre Market
Last Updated: 13:10:03
Delayed by 15 minutes
Share Name Share Symbol Market Type
US Physical Therapy Inc NYSE:USPH NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 94.48 2 13:10:03

U.S. Physical Therapy Reports First Quarter 2015 Results

07/05/2015 1:30pm

Business Wire


US Physical Therapy (NYSE:USPH)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more US Physical Therapy Charts.

Company Declares $.15 Per Share Quarterly Dividend

U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics, today reported results for the first quarter ended March 31, 2015.

U.S. Physical Therapy’s net income attributable to common shareholders prior to revaluation of redeemable non-controlling interests, net of tax (“operating results”) was $4.2 million for the first quarter of 2015 and for the first quarter of 2014. Diluted earnings per share from operating results were $.34 in the recent quarter as compared to $.35 in the comparable 2014 period. As noted in the Company’s press release on March 5, the unusually severe winter weather prevalent in many parts of the country during the first quarter adversely impacted operations. Management estimates that more than 20,000 patient visits were cancelled with an earnings impact of $.07 to $.09 per share.

First Quarter 2015 Compared to First Quarter 2014

  • Net revenues increased 10.7% from $69.8 million in the first quarter of 2014 to $77.2 million in the first quarter of 2015, due to an increase in total patient visits of 10.7% from 643,900 to 712,900 and a slight increase in the average net revenue per visit to $106.34 from $106.23. Net revenues from new clinics opened or acquired in the past 12 months was $6.2 million.
  • Total clinic operating costs were $60.4 million, or 78.2% of net revenues, in the first quarter of 2015, as compared to $53.1 million, or 76.1% of net revenues, in the 2014 period. The increase was primarily attributable to $5.5 million in operating costs of new clinics opened or acquired in the past 12 months. Total clinic salaries and related costs, including those from new clinics, were 55.7% of net revenues in the recent quarter versus 54.4% in the 2014 period. Rent, clinic supplies, contract labor and other costs as a percentage of net revenues were 21.1% for the recent quarter versus 20.4% in the 2014 period. The provision for doubtful accounts as a percentage of net revenues was 1.3% for the 2015 period and 1.4% in the 2014 period.
  • The gross margin for the first quarter of 2015 was $16.8 million or 21.8%, as compared to $16.6 million or 23.9% for the 2014 quarter.
  • Corporate office costs were $7.7 million in the first quarter of 2015 compared to $7.1 million in the 2014 first quarter. Corporate office costs were 9.9% of net revenues for the 2015 quarter compared to 10.2% of net revenues for the 2014 quarter.
  • Operating income for the recent quarter was $9.2 million compared to $9.5 million in the 2014 first quarter.
  • Interest expense was $0.3 million in the first quarter of 2015 and 2014.
  • The provision for income taxes for the 2015 period was $2.8 million and for the 2014 period $2.9 million. The provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interest was 40.0% in the 2015 first quarter and 41.0% in the 2014 first quarter.
  • Net income attributable to non-controlling interests was $2.0 million in the recent quarter as compared to $2.1 million in the year earlier period.
  • Operating results attributable to common shareholders for the three months ended March 31, 2015 and 2014 was consistent at $4.2 million for each period. Diluted earnings per share from operating results were $0.34 for the 2015 period and $0.35 for the 2014 period.
  • Same store visits increased 3.8% for de novo and acquired clinics open for one year or more and same store revenue increased 4.2% as the average net rate per visit increased by $.40.

Chris Reading, Chief Executive Officer, said, “This was undoubtedly a difficult quarter from a weather perspective yet there were a number of bright spots including solid same store visit growth, strong referral volume and a couple of acquisitions closed in the early part of this year. I continue to have great confidence in our team and in our collective ability to execute on our plan for 2015.”

Larry McAfee, Chief Financial Officer, noted, “By mid-March, after the winter storms subsided, the Company’s average daily patient visits rose significantly such that we ended the first quarter at a solid run rate. Absent the severe weather, patient visits in the first quarter would have been higher as same store patient referrals increased a strong 4.6%.”

U.S. Physical Therapy Declares Quarterly Dividend

The second quarterly dividend of 2015 for $.15 per share will be paid on June 5 to shareholders of record as of May 18.

First Quarter 2015 Conference Call

U.S. Physical Therapy's Management will host a conference call at 10:30 a.m. Eastern Time, 9:30 a.m. Central Time, on Thursday, May 7, 2015 to discuss the Company’s Quarter Ended March 31, 2015 results. Interested parties may participate in the call by dialing 1-888-335-5539 or 973-582-2857 and entering reservation number 22675485 approximately 10 minutes before the call is scheduled to begin. To listen to the live call via web-cast, go to the Company's website at www.usph.com at least 15 minutes early to register, download and install any necessary audio software. The conference call will be archived and can be accessed until July 7, 2015.

Forward-Looking Statements

This press release contains statements that are considered to be forward-looking within the meaning under Section 21E of the Securities Exchange Act of 1934, as amended. These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as “believes”, “expects”, “intends”, “plans”, “appear”, “should” and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we expect. Included among such statements may be those relating to new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:

  • changes as the result of government enacted national healthcare reform;
  • changes in Medicare guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status;
  • business and regulatory conditions including federal and state regulations;
  • governmental and other third party payor investigations and audits;
  • compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply;
  • changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
  • transition to ICD-10 coding system;
  • revenue and earnings expectations;
  • general economic conditions;
  • availability and cost of qualified physical and occupational therapists;
  • personnel productivity;
  • competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
  • acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses;
  • maintaining adequate internal controls;
  • availability, terms, and use of capital; and
  • weather and other seasonal factors.

Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this press release. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer applicable.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 497 outpatient physical and occupational therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 17 physical therapy facilities for third parties, including hospitals and physician groups.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.

           

U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF NET INCOME(IN THOUSANDS, EXCEPT PER SHARE DATA)(unaudited)

  Three Months Ended March 31, 2015 March 31, 2014 Net patient revenues $ 75,807 $ 68,397 Other revenues   1,434     1,370   Net revenues 77,241 69,767 Clinic operating costs: Salaries and related costs 43,052 37,942 Rent, clinic supplies, contract labor and other 16,325 14,216 Provision for doubtful accounts 990 950 Closure costs   32     13   Total clinic operating costs   60,399     53,121   Gross margin 16,842 16,646 Corporate office costs   7,657     7,132   Operating income 9,185 9,514 Interest and other income, net 8 1 Interest expense   (265 )   (253 ) Income before taxes 8,928 9,262 Provision for income taxes   2,777     2,939   Net income including non-controlling interests 6,151 6,323 Less: net income attributable to non-controlling interests   (1,985 )   (2,095 ) Net income attributable to common shareholders $ 4,166   $ 4,228   Basic earnings per share attributable to common shareholders: From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35 Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -     (0.08 ) Basic $ 0.34   $ 0.27     Diluted earnings per share attributable to common shareholders: From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35 Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -     (0.08 ) Diluted $ 0.34   $ 0.27   Shares used in computation: Basic   12,313     12,129   Diluted   12,313     12,144     Dividends declared per common share $ 0.15   $ 0.12  

         

U.S. PHYSICAL THERAPY, INC AND SUBSIDIARIES

CONSOLIDATED EARNINGS PER SHARE

(IN THOUSANDS, EXCEPT PER SHARE DATA)

(unaudited)

 

Three Months Ended March 31, 2015 March 31, 2014 Earnings attributable to common shareholders: From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 4,166 $ 4,228 Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -   (967 ) $ 4,166 $ 3,261   Basic earnings per share attributable to common shareholders: From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35 Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -   (0.08 ) $ 0.34 $ 0.27   Diluted earnings per share attributable to common shareholders: From operations prior to revaluation of redeemable non-controlling interests, net of tax $ 0.34 $ 0.35 Charges to additional paid-in-capital - revaluation of redeemable non-controlling interests, net of tax   -   (0.08 ) $ 0.34 $ 0.27   Shares used in computation: Basic earnings per share - weighted-average shares 12,313 12,129 Effect of dilutive securities - stock options   -   15  

Denominator for diluted earnings per share - adjusted weighted-average shares

 

12,313   12,144  

            U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(IN THOUSANDS, EXCEPT SHARE DATA)   March 31, 2015 December 31, 2014 ASSETS (unaudited) Current assets: Cash and cash equivalents $ 14,557 $ 14,271 Patient accounts receivable, less allowance for doubtful accounts of $1,633 and $1,669, respectively 34,673 32,891 Accounts receivable - other, less allowance for doubtful accounts of $198 and $198, respectively 1,378 1,503 Other current assets   5,291     6,186   Total current assets 55,899 54,851 Fixed assets: Furniture and equipment 42,542 42,003

Leasehold improvements

  23,565     22,806   66,107 64,809 Less accumulated depreciation and amortization   50,212     49,045   15,895 15,764 Goodwill 159,176 147,914 Other intangible assets, net 24,537 24,907 Other assets   1,916     1,115   $ 257,423   $ 244,551     LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable - trade $ 2,292 $ 1,782 Accrued expenses 18,178 22,839 Current portion of notes payable   932     883   Total current liabilities 21,402 25,504 Notes payable 483 234 Revolving line of credit 41,500 34,500 Deferred rent 984 991 Other long-term liabilities   9,480     8,732   Total liabilities 73,849 69,961 Commitments and contingencies Redeemable non-controlling interests 7,373 7,376 Shareholders' equity:

U.S. Physical Therapy, Inc. shareholders' equity:

Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding - - Common stock, $.01 par value, 20,000,000 shares authorized, 14,613,374 and 14,487,346 shares

issued, respectively

145 145 Additional paid-in capital 45,080 43,577 Retained earnings 136,491 134,186 Treasury stock at cost, 2,214,737 shares   (31,628 )   (31,628 )

Total U.S. Physical Therapy, Inc. shareholders' equity

150,088 146,280 Non-controlling interests   26,113     20,934   Total equity   176,201     167,214   $ 257,423   $ 244,551  

            U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS(IN THOUSANDS, EXCEPT PER SHARE DATA)(unaudited)   Three Months Ended March 31, 2015 March 31, 2014 OPERATING ACTIVITIES Net income including non-controlling interests $ 6,151 $ 6,323 Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities: Depreciation and amortization 1,807 1,387 Provision for doubtful accounts 991 950 Equity-based awards compensation expense 990 735 Loss on sale of business and sale or abandonment of assets, net 17 19 Excess tax benefit from shared-based compensation (271 ) (126 ) Deferred income tax 565 1,580 Write-off of goodwill - closed clinic 34 - Changes in operating assets and liabilities: Increase in patient accounts receivable (2,185 ) (3,002 ) Decrease in accounts receivable - other 125 146 Decrease in other assets 106 735 (Decrease) in accounts payable and accrued expenses (5,976 ) (5,241 ) Increase in other Long term liabilities   665     184   Net cash provided by operating activities 3,019 3,690 INVESTING ACTIVITIES Purchase of fixed assets (1,419 ) (849 ) Purchase of businesses, net of cash acquired (6,445 ) (125 ) Acquisitions of non-controlling interests (359 ) (2,833 ) Proceeds on sale of business and fixed assets, net   8     16   Net cash used in investing activities (8,215 ) (3,791 ) FINANCING ACTIVITIES Distributions to non-controlling interests (including redeemable non-controlling interests) (1,589 ) (1,413 ) Proceeds from revolving line of credit 34,000 29,000 Payments on revolving line of credit (27,000 ) (23,500 ) Payment of notes payable (200 ) (250 ) Tax benefit from share-based compensation 271 126 Other   -     1   Net cash provided by financing activities 5,482 3,964 Net increase in cash and cash equivalents 286 3,863 Cash and cash equivalents - beginning of period   14,271     12,898   Cash - end of period $ 14,557   $ 16,761   SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Cash paid during the period for: Income taxes $ 1,275 $ 242 Interest $ 235 $ 345 Non-cash investing and financing transactions during the period: Purchase of business - seller financing portion $ 500 $ - Revaluation of redeemable non-controlling interests $ - $ 1,639

      U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIESRECAP OF CLINIC COUNT   Number of Date Clinics   March 31, 2014 472 June 30, 2014 486 September 30, 2014 489 December 31, 2014 489   March 31, 2015 494

U.S. Physical Therapy, Inc.Larry McAfee, (713) 297-7000Chief Financial OfficerorChris Reading, (713) 297-7000Chief Executive OfficerorWestwicke PartnersBob East, (443) 213-0502

1 Year US Physical Therapy Chart

1 Year US Physical Therapy Chart

1 Month US Physical Therapy Chart

1 Month US Physical Therapy Chart